Man Liu1, Guangbin Shi1, Kai-Chien Yang2, Lianzhi Gu3, Anumantha G Kanthasamy4, Vellareddy Anantharam4, Samuel C Dudley5. 1. Division of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island. 2. Division of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island; Graduate Institute of Pharmacology, National Taiwan University School of Medicine, Taipei City, Taiwan. 3. Section of Cardiology, University of Illinois at Chicago, Chicago, Illinois. 4. Department of Biomedical Sciences, Iowa Center for Advanced Neurotoxicology, Iowa State University, Ames, Iowa. 5. Division of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island; Providence VA Medical Center, Providence, Rhode Island. Electronic address: samuel_dudley@brown.edu.
Abstract
BACKGROUND: The reduced form of nicotinamide adenine dinucleotide (NADH) increases in cardiomyopathy, activates protein kinase C (PKC), up-regulates mitochondrial reactive oxygen species (mitoROS), and down-regulates the cardiac Na+ channel (NaV1.5). OBJECTIVE: The purpose of this study was to determine how NADH signals down-regulation of NaV1.5. METHODS: Isolated mouse cardiomyocytes were used for patch-clamp recording and for monitoring mitoROS with MitoSOX Red. HEK293 cells were used for transient transfections. HEK293 cells stably expressing human NaV1.5 were used for single channel recording, whole-cell patch-clamp recording, activity measurements of phospholipase C and phospholipase D (PLD), channel protein purification, and co-immunoprecipitation with PKC isoforms. HL-1 cells were used for mitochondria isolation. RESULTS: NADH enhanced PLD activity (1.6- ± 0.1-fold, P <.01) and activated PKCδ. Activated PKCδ translocated to mitochondria and up-regulated mitoROS (2.8- ± 0.3-fold, P <.01) by enhancing the activities of mitochondrial complexes I, II, and IV (1.1- to 1.5-fold, P <.01). PKCδ also interacted with NaV1.5 to down-regulate Na+ current (INa). Reduction in INa by activated PKCδ was prevented by antioxidants and by mutating the known PKC phosphorylation site S1503. At the single channel level, the mechanism of current reduction by PKC and recovery by protein kinase A was a change in single channel conductance. CONCLUSION: NADH activated PKCδ by enhancing PLD activity. PKCδ modulated both mitoROS and NaV1.5. PKCδ elevated mitoROS by enhancing mitochondrial oxidative phosphorylation complex activities. PKCδ-mediated channel phosphorylation and mitoROS were both required to down-regulate NaV1.5 and alter single channel conductance. Copyright Â
BACKGROUND: The reduced form of nicotinamide adenine dinucleotide (NADH) increases in cardiomyopathy, activates protein kinase C (PKC), up-regulates mitochondrial reactive oxygen species (mitoROS), and down-regulates the cardiac Na+ channel (NaV1.5). OBJECTIVE: The purpose of this study was to determine how NADH signals down-regulation of NaV1.5. METHODS: Isolated mouse cardiomyocytes were used for patch-clamp recording and for monitoring mitoROS with MitoSOX Red. HEK293 cells were used for transient transfections. HEK293 cells stably expressing humanNaV1.5 were used for single channel recording, whole-cell patch-clamp recording, activity measurements of phospholipase C and phospholipase D (PLD), channel protein purification, and co-immunoprecipitation with PKC isoforms. HL-1 cells were used for mitochondria isolation. RESULTS:NADH enhanced PLD activity (1.6- ± 0.1-fold, P <.01) and activated PKCδ. Activated PKCδ translocated to mitochondria and up-regulated mitoROS (2.8- ± 0.3-fold, P <.01) by enhancing the activities of mitochondrial complexes I, II, and IV (1.1- to 1.5-fold, P <.01). PKCδ also interacted with NaV1.5 to down-regulate Na+ current (INa). Reduction in INa by activated PKCδ was prevented by antioxidants and by mutating the known PKC phosphorylation site S1503. At the single channel level, the mechanism of current reduction by PKC and recovery by protein kinase A was a change in single channel conductance. CONCLUSION:NADH activated PKCδ by enhancing PLD activity. PKCδ modulated both mitoROS and NaV1.5. PKCδ elevated mitoROS by enhancing mitochondrial oxidative phosphorylation complex activities. PKCδ-mediated channel phosphorylation and mitoROS were both required to down-regulate NaV1.5 and alter single channel conductance. Copyright Â
Authors: Alastair W Poole; Giordano Pula; Ingeborg Hers; David Crosby; Matthew L Jones Journal: Trends Pharmacol Sci Date: 2004-10 Impact factor: 14.819
Authors: Megan M McNulty; Gabrielle B Edgerton; Ravi D Shah; Dorothy A Hanck; Harry A Fozzard; Gregory M Lipkind Journal: J Physiol Date: 2007-03-15 Impact factor: 5.182
Authors: Carmen R Valdivia; William W Chu; Jielin Pu; Jason D Foell; Robert A Haworth; Mathew R Wolff; Timothy J Kamp; Jonathan C Makielski Journal: J Mol Cell Cardiol Date: 2005-03 Impact factor: 5.000
Authors: Gad A Silberman; Tai-Hwang M Fan; Hong Liu; Zhe Jiao; Hong D Xiao; Joshua D Lovelock; Beth M Boulden; Julian Widder; Scott Fredd; Kenneth E Bernstein; Beata M Wolska; Sergey Dikalov; David G Harrison; Samuel C Dudley Journal: Circulation Date: 2010-01-18 Impact factor: 29.690
Authors: Alexander Panov; Peter Schonfeld; Sergey Dikalov; Richelle Hemendinger; Herbert L Bonkovsky; Benjamin Rix Brooks Journal: J Biol Chem Date: 2009-03-20 Impact factor: 5.157
Authors: Michael Hambleton; Allen York; Michelle A Sargent; Robert A Kaiser; John N Lorenz; Jeffrey Robbins; Jeffery D Molkentin Journal: Am J Physiol Heart Circ Physiol Date: 2007-10-05 Impact factor: 4.733
Authors: Daniel S Matasic; Jin-Young Yoon; Jared M McLendon; Haider Mehdi; Mark S Schmidt; Alexander M Greiner; Pravda Quinones; Gina M Morgan; Ryan L Boudreau; Kaikobad Irani; Charles Brenner; Barry London Journal: J Mol Cell Cardiol Date: 2020-03-21 Impact factor: 5.000
Authors: Man Liu; Hong Liu; Preethy Parthiban; Gyeoung-Jin Kang; Guangbin Shi; Feng Feng; Anyu Zhou; Lianzhi Gu; Courtney Karnopp; Elena G Tolkacheva; Samuel C Dudley Journal: J Clin Invest Date: 2021-09-15 Impact factor: 14.808
Authors: Nilüfer N Turan; Karni S Moshal; Karim Roder; Brett C Baggett; Anatoli Y Kabakov; Saroj Dhakal; Ryota Teramoto; David Yi-Eng Chiang; Mingwang Zhong; An Xie; Yichun Lu; Samuel C Dudley; Calum A MacRae; Alain Karma; Gideon Koren Journal: J Biol Chem Date: 2020-10-22 Impact factor: 5.157